BioSpace News Archive

Senhwa Biosciences, Inc. (TPEx: 6492), announced today that the first patient with severe COVID-19 demonstrated remarkable recovery after treatment with the Company’s investigational drug, Silmitasertib.

The bill from Rep. Robin Kelly (D-IL) extends protections to low-income and minority communities during COVID-19

Experion Holdings Ltd. (the “Company” or “Experion”) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that its Chief Financial Officer Kamini Hitkari has advised the Company of her decision to resign from the Company to pursue another opportunity.

Owing to a high incidence of chronic diseases, the home infusion therapy market is witnessing uptick in demand.

Unblinded Subgroup Analyses Show Consistent Effect for MRI Lesion Suppression Across Different Populations

Acasti Pharma Inc. announced that it has filed and mailed the information circular and management proxy statement for its upcoming annual and special meeting of shareholders to be held on September 30, 2020.

Zentalis Pharmaceuticals, Inc. announced that it will host a Key Opinion Leader virtual meeting on its clinical candidate ZN-c3, the Company’s WEE1 inhibitor, and its potential in the treatment of advanced solid tumors on Thursday, September 24, 2020 from 12:00 p.m. to 1:30 p.m. EDT.

Editas Medicine, Inc. announced the U.S. Patent and Trademark Office issued a decision in an interference between the University of California, the University of Vienna, Emmanuelle Charpentier and the Broad Institute, Inc. regarding certain Broad CRISPR/Cas9 patents Editas Medicine exclusively licenses.

Centene Corporation announced that it plans to expand its offering in the 2021 Health Insurance Marketplace.

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Wei-Wu He, Chairman and Chief Executive Officer of CASI Pharmaceuticals, will be presenting at the following upcoming virtual conferences in September.